Endovascular Engineering, Inc. ("E2") has secured $42 million in an oversubscribed Series B financing to advance its next generation clot removal technology platform for venous thromboembolism (VTE).

Honda Motor Co. (Middle East & Africa Office) unveiled its complete lineup of BF Marine Engines at the Dubai Boat Sho ...

HR leaders are under increasing pressure to reduce these costs through innovative benefit strategies and employee engagement initiatives. However, due to budget constraints and small internal teams, ...

MICHIGAN CITY, INDIANA / ACCESS Newswire / February 18, 2025 / DwyerOmega, a leader in sensing and measurement technologies, ...

LEXINGTON, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Mimecast, a global cybersecurity leader transforming the way businesses manage and mitigate human risk, announced today the appointment of Adenike ...

The ability to discern, curate, and refine that intangible "eye" for greatness will always remain profoundly human. Unless, ...

With the first practice session of the new IndyCar season due to begin at St. Petersburg on Friday, Feb. 28, it’s time to ...

It was a Wednesday morning at 19 Carter in Berlin. The guests, who had come by for the weekly coffee hour, were gathered ...

Q4 2024 Earnings Call Transcript February 18, 2025 Blackbaud, Inc. reports earnings inline with expectations. Reported EPS is ...

Welcome to Amplitude's fourth quarter and full year 2024 earnings call. I'm John Streppa, head of investor relations. Joining ...